Octave’s MS disease activity test now available across US

Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, which uses data from blood biomarkers to assess multiple sclerosis (MS) disease activity, is now available across all 50 U.S. states to help guide clinicians’ decisions about care. Octave said the test received certification from the New York State Clinical…

Blood test for antibody clumps may support MS diagnosis

Measuring the amount of specific antibody clumps in the blood helped distinguish people with multiple sclerosis (MS) from healthy individuals and people with other conditions with an accuracy of at least 90%, a new study has found. The findings show that clumps of immunoglobulin G (IgG) antibodies — which…

Acrolein Eyed as Potential Biomarker of MS, Preliminary Study Finds

A product called acrolein, which is naturally excreted by the body and possible to measure in urine and blood, may be a potential biomarker to help diagnose and evaluate disease activity in people with multiple sclerosis (MS), according to preliminary research in animal models and humans. Researchers are investigating whether acrolein…